Reviva Pharmaceuticals Holdings, Inc. (RVPH)
OTCMKTS · Delayed Price · Currency is USD
0.5950
-0.0050 (-0.83%)
At close: Jun 2, 2026

RVPH Stock Forecast

OTC-RVPH's stock price has decreased by -96.91% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 3 analysts polled by S&P Global, RVPH stock has a consensus rating of "Strong Buy" and an average price target of $25. The average 1-year stock price forecast is 4,101.68% higher than the current stock price, while the lowest is $5.00 (+740.34%) and the highest is $40 (+6,622.69%).

Price Target: $25 (+4,101.68%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$5.00$25$30$40
Change+740.34%+4101.7%+4942.0%+6622.7%

Analyst Ratings

The average analyst rating for RVPH stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingDec '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy665442
Buy111100
Hold000110
Sell000000
Strong Sell000000
Total776652

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Alliance Global Partners
Alliance Global Partners
Buy
Reiterates
$30
BuyReiterates$30+4,942.02%May 21, 2026
Maxim Group
Maxim Group
Hold
Downgrades
n/a
HoldDowngradesn/an/aApr 8, 2026
Roth MKM
Roth MKM
Buy
Reiterates
$1.5$1
BuyReiterates$1.5$1+68.07%Apr 1, 2026
D. Boral Capital
D. Boral Capital
Hold
Downgrades
n/a
HoldDowngradesn/an/aMar 5, 2026
Chardan Capital
Chardan Capital
Buy
Maintains
$40
BuyMaintains$40+6,622.69%Jan 5, 2026
More Analyst Ratings
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.